Employees at Achilles Therapeutics are bracing themselves for job losses after the UK biotech announced that it is dropping ...

Achilles Therapeutics has announced it will discontinue its tumor-infiltrating lymphocyte (TIL)-based clonal neoantigen T ...

Researchers at Saint Louis University School of Medicine investigated differences in T-cell responses between male and female ...

Antibiotics are a lifesaving tool. Yet, due to their chronic overuse, microbes are evolving and developing immunity against ...

The firm is discontinuing its CHIRON and THETIS trials after lackluster data and is planning for potential third-party deals and workforce layoffs.

A recently held Enosophia event delved deeper into the roles of Graševina & Frankovka, the Slavonian yin & yang.